PAHC analyst estimates
Phibro Animal Health (PAHC) analyst ratings, the average price target and its range, and every firm's latest call.
PAHC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Feb 6, 2026 | Morgan Stanley | Phibro Animal Health price target raised to $49 from $45 at Morgan Stanley | $49.00 |
| Aug 28, 2025 | Morgan Stanley | Phibro Animal Health price target raised to $34 from $26 at Morgan Stanley | $34.00 |
| Jun 25, 2025 | Morgan Stanley | Phibro Animal Health price target raised to $26 from $21 at Morgan Stanley | $26.00 |
| Apr 15, 2025 | Morgan Stanley | Phibro Animal Health price target lowered to $20 from $27 at Morgan Stanley | $20.00 |
| Dec 21, 2022 | Roth Capital | Roth Capital Initiates Coverage On Phibro Animal Health with Buy Rating, Announces Price Target of $18 | $18.00 |
| Sep 16, 2022 | Barclays | Barclays Maintains Underweight on Phibro Animal Health, Lowers Price Target to $17 | $17.00 |
| Aug 26, 2022 | Morgan Stanley | Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Lowers Price Target to $21 | $21.00 |
- 2 firms rate PAHC: 1 buy, 1 hold, 0 sell.
Updated 2026-11-05 12:47 UTC